Recombinant Human Anti-CD89 x Human Anti-malaria antigen Bispecific Antibody (scIgG)  (SCIGG-H307)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD89 and anti-malaria antigen IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet